OncogeneCancer BiologyPeer-reviewed journal article
Identification of Raptor and GLI1 as USP37 substrates highlight its context-specific function in medulloblastoma cells.
Ashutosh Kumar SinghiD, Donghang ChengiD, Amanda R. HaltomiD, Yanwen YangiD, Tara DobsoniD, Rashieda J. Hatcher, Veena RajaramiD, Vidya GopalakrishnaniD
Abstract
USP37 gene encodes a deubiquitylase (DUB), which catalyzes the proteolytic removal of ubiquitin moieties from proteins to modulate their stability, cellular localization or activity. Its expression is downregulated in a subgroup of medulloblastomas driven by constitutive activation of sonic hedgehog (SHH) signaling. Patients with SHH-driven medulloblastomas with elevated expression of the RE1 silencing transcription factor (REST) and reduced expression of USP37 have poor outcomes. In previous studies, we showed sustained proliferation of SHH-medulloblastoma cells due to blockade of terminal cell cycle exit and neuronal differentiation stemming from a failure in USP37-dependent stabilization of its target, the cyclin-dependent kinase inhibitor (CDKI)-p27. This finding suggested a tumor suppressive function for USP37. Interestingly, the current study also uncovered Raptor, a component of the mTORC1 complex, as a novel target of USP37. Under conditions of low-USP37 expression, reduced Raptor stability and mTORC1 activity caused a decline in phosphorylation of 4E-binding protein 1 (4EBP1) and increased its interaction with eukaryotic elongation factor 4E (eIF4E), which is known to inhibit CAP-dependent translation initiation. Surprisingly, a subset of patients with SHH-driven medulloblastomas with elevated expression of USP37 and the Glioma associated Oncogene 1 (GLI1), also exhibited poor outcomes. Using genetic and biochemical analyses, we showed that USP37-mediated stabilization of GLI1, a terminal effector of SHH signaling, increases pathway activity and upregulates expression of its target oncogene products, NMYC and CCND1, to drive cell proliferation. These data indicate that USP37 elevation in SHH-driven medulloblastomas has the potential to promote non-canonical activation of SHH signaling. Overall, our findings suggest that USP37 may have context-specific oncogenic and tumor suppressive roles in medulloblastoma cells.
- Citations
- 3
- FWCI
- 0.90
- Field percentile
- top 27%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting Nuclear Factor I/B (NFIB)
N. Perumal, R. Kanchan, … S. Mahapatra·bioRxiv·Apr 15, 2021
- Ras-Responsive Element Binding Protein 1 regulates survival of Group 3 medulloblastoma
Meher Beigi Masihi, Kendall R. Chambers, … Robert J. Wechsler‐Reya·bioRxiv·Jul 16, 2025
- Disrupting USP39 deubiquitinase Function Impairs the Survival and Migration of Multiple Myeloma Cells through ZEB1 Degradation
Jessy Sirera, Saharnaz Sarlak, … Frédéric Luciano·Journal of Experimental & Clinical Cancer ResearchPeer-reviewed·Dec 30, 2024
- USP7 inhibition perturbs proteostasis and tumorigenesis in triple negative breast cancer
Ahhyun Kim, Priya Gopalakrishnan, … Claudia A. Benavente·npj Breast CancerPeer-reviewed·May 23, 2026
- Multifaceted functions of Rab23 on primary cilium and Hedgehog signaling-mediated granule cell proliferation
Catherine Hong Huan Hor, J. C. W. Lo, … Eyleen L. K. Goh·Journal of NeurosciencePeer-reviewed·Jul 1, 2021
- Identification and validation of E3 ubiquitin ligase XIAP as a novel substrate of deubiquitinase USP7 (HAUSP) - Implication towards oncogenesis
G. Saha, S. Sarkar, … M. K. Ghosh·bioRxiv·Aug 12, 2021